suPARnostic® will now be available for clinical decision making at Sygehus Lillebaelts two hospitals in Kolding and Vejle, Denmark. Both hospitals use the cobas system from Roche Diagnostics, an instrument line that was validated by ViroGates for use of the suPARnostic® TurbiLatex test earlier this year.

Read the Journal "suPAR News" No. 2, 2019 - with lots of interesting articles and interviews from around Europe!

suPARnostic® will now be available for clinical decision making in the University Hospital of Montpellier, France.
It will be the first hospital in the world to run suPARnostic® TurbiLatex at the Roche cobas 8000 system.

ViroGates and QIAGEN announces a partnership to launch suPARnostic® Quick Triage on QIAGEN’s automated Lateral Flow (aLF) platform.

ViroGates is expanding and has employed yet another two employees; new Global Partner Director and new CFO.

New abstract published in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine;

"Availability of suPAR in emergency departments may improve risk stratification: A secondary analysis of the TRIAGE III trial" by Schultz M et al.